Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diaphragmatic myasthenia in mother and child.

Literature DB >> 4034463

Diaphragmatic myasthenia in mother and child.

Abstract

A 28 year old patient with ocular myasthenia for 2 y gave birth to a baby with diaphragmatic weakness. Following delivery the mother developed severe weakness of the diaphragm and required assisted ventilation. The baby recovered spontaneously and the mother responded to treatment with plasma exchange and immunosuppression. Neither mother nor baby responded to anticholinergic drugs and in neither serum were acetyl choline receptor antibodies detected.

Entities: Chemical Disease Species

Mesh：

Year: 1985 PMID： 4034463 PMCID： PMC2418358 DOI： 10.1136/pgmj.61.718.725

Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401

12 in total

1. Abdominal and thoracic pressures at different lung volumes.

Authors: E AGOSTONI; H RAHN
Journal: J Appl Physiol Date: 1960-11 Impact factor: 3.531

Review 2. Myasthenia gravis (first of two parts).

Authors: D B Drachman
Journal: N Engl J Med Date: 1978-01-19 Impact factor: 91.245

3. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors: D M Fambrough; D B Drachman; S Satyamurti
Journal: Science Date: 1973-10-19 Impact factor: 47.728

4. Anti-acetylcholine receptor antibody in neonatal myasthenia gravis.

Authors: J Keesey; J Lindstrom; H Cokely
Journal: N Engl J Med Date: 1977-01-06 Impact factor: 91.245

Review 5. Autoimmune thyroid disease and pregnancy.

Authors: T F Davies; I Weiss
Journal: Am J Reprod Immunol Date: 1981-08 Impact factor: 3.886

6. Myasthenia gravis: evaluation of treatment in 1,355 patients.

Authors: V P Perlo; D C Poskanzer; R S Schwab; H R Viets; K E Osserman; G Genkins
Journal: Neurology Date: 1966-05 Impact factor: 9.910

7. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors: J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal: Neurology Date: 1976-11 Impact factor: 9.910

8. Antiacetylcholine receptor antibody in neonatal myasthenia gravis.

Authors: J O Donaldson; A S Penn; R P Lisak; O Abramsky; T Brenner; D L Schotland
Journal: Am J Dis Child Date: 1981-03

9. End-plate potentials in experimental autoimmune myasthenia gravis in rats.

Authors: E H Lambert; J M Lindstrom; V A Lennon
Journal: Ann N Y Acad Sci Date: 1976 Impact factor: 5.691

10. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.

Authors: J Newsom-Davis; A J Pinching; A Vincent; S G Wilson
Journal: Neurology Date: 1978-03 Impact factor: 9.910

5 in total

1. Long term treatment of myasthenia gravis with azathioprine.

Authors: V Fonseca; C W Havard
Journal: Postgrad Med J Date: 1990-02 Impact factor: 2.401

2. Unsuspected myasthenia gravis presenting as respiratory failure.

Authors: A Mier; C Laroche; M Green
Journal: Thorax Date: 1990-05 Impact factor: 9.139

Review 3. New treatment approaches to myasthenia gravis.

Authors: C W Havard; V Fonseca
Journal: Drugs Date: 1990-01 Impact factor: 9.546

4. Effect of sera from seronegative myasthenia gravis patients on neuromuscular junctions.

Authors: Rumi Sato; Shiho Imamoto; Iku Utsnomiya; Terumasa Chiba; Kyoji Taguchi; Kenji Abe; Keiko Tanaka; Tadashi Miyatake
Journal: Neurol Sci Date: 2013-02-07 Impact factor: 3.307

5. Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line.

Authors: R Barrett-Jolley; N Byrne; A Vincent; J Newsom-Davis
Journal: Pflugers Arch Date: 1994-10 Impact factor: 3.657

5 in total